[Monitoring of bone metastases].

Abstract

Current knowledge about an incidence of bone metastases, use of bisphosphonates and assessment of response to the treatment are surveyed. The bone metastases are quite frequent in patients with breast and prostate cancers. High doses of intravenous pamidronate are particularly useful in the treatment of these patients. Prior to therapy with bisphosphonate special score elaborated by RE Coleman should be calculated. The new biochemical bone resorption markers especially Ntx i Crosslaps seems to be the most efficient for evaluation metastases response.

• Authors: J Pawlega, A Adamczyk
• Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (Pol Merkur Lekarski) Vol. 8 Issue 45 Pg. 151-4 (Mar 2000) ISSN: 1426-9686 [Print] Poland
• Vernacular Title: Monitorowanie leczenia przerzutów nowotworowych do kości.
• PMID: 10870423 (Publication Type: Journal Article, Review)

Chemical References

• Antineoplastic Agents
• Diphosphonates
• Pamidronate

Topics

• Antineoplastic Agents (therapeutic use)
• Bone Neoplasms (drug therapy, secondary)
• Diphosphonates (therapeutic use)
• Humans
• Injections, Intravenous
• Neoplasms, Second Primary
• Pamidronate
• Treatment Outcome